PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0011854|type 1 diabetes |
| Sentences | 45 |
| PubMedID- 23216128 | Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with type 1 diabetes. |
| PubMedID- 20619918 | Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. |
| PubMedID- 21080740 | There was a beneficial effect of intensive glucose control on cardiovascular disease in patients with type 1 diabetes in only one trial. |
| PubMedID- 24843643 | It was also reported that plasma levels of e‐selectin are positively correlated with albuminuria and cardiovascular disease in patients with type 1 diabetes25. |
| PubMedID- 24771008 | Epidemiology of cardiovascular disease in patients with type 1 diabetes: european perspective. |
| PubMedID- 22526620 | Poorly managed type 1 diabetes can lead to cardiovascular disease, diabetic neuropathy, and diabetic retinopathy. |
| PubMedID- 21270199 | Thus, ages may explain, in part, the increased cardiovascular disease and mortality attributable to type 1 diabetes and constitute a specific target for treatment in these patients. |
| PubMedID- 20978091 | Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes. |
| PubMedID- 23757599 | Previous studies have reported that cimt is increased in children at high risk for cardiovascular disease because of familial hypercholesterolemia, type 1 diabetes, having parents with premature myocardial infarction, or elevated levels of ultrasensitive c-reactive protein compared with other children (jarvisalo et al. |
| PubMedID- 24396666 | Other recent reports showed that variations in long-term glycemia, defined as a1c variability, were powerful independent predictors for diabetic microvascular complications and even for cardiovascular disease (cvd) events in patients with type 1 diabetes [12,20]. |
| PubMedID- 22422191 | Mortality of cardiovascular diseases in patients with type 1 diabetes is increased 2- to 20-fold compared to non-diabetic individuals. |
| PubMedID- 26078757 | Opg is associated with poor glycaemic control and cardiovascular disease (cvd) in patients with type 1 diabetes, compatible with the hypothesis that opg is associated with the development of diabetic vascular complications [31]. |
| PubMedID- 24654672 | Whilst the number of deaths as a result of ketoacidosis or severe hypoglycaemia is lower than for cardiovascular disease in people with type 1 diabetes, these acute metabolic decompensations cause 9–13% of deaths in adults 1,2, with a higher proportion of 20–44% of deaths in children and young adults (excluding ketoacidosis at diagnosis) 1–5. |
| PubMedID- 26491340 | Background: hypertension is a highly prevalent risk factor for cardiovascular disease in patients with type 1 diabetes mellitus. |
| PubMedID- 25099744 | Objective: dyslipidemia contributes to the increased risk of cardiovascular disease in persons with type 1 diabetes (t1d). |
| PubMedID- 20622162 | It certainly may be that this rapid aging of apoa-1, a key protein in lipoprotein metabolism, causes the known higher risk for macrovascular disease in people with type 1 diabetes (20). |
| PubMedID- 26202844 | Postprandial bgls have been shown to increase the risk factors for cardiovascular disease in people with type 1 diabetes [13, 14]. |
| PubMedID- 25903071 | In a recent meta-analysis, the excess risk of fatal cardiovascular disease in persons with type 1 diabetes was twice as high in women compared with men [20••]. |
| PubMedID- 21871097 | Background: the presence of microalbuminuria can be associated with overt nephropathy and cardiovascular disease in patients with type 1 diabetes (t1d). |
| PubMedID- 21627687 | A new model for 5-year risk of cardiovascular disease in type 1 diabetes; from the swedish national diabetes register (ndr). |
| PubMedID- 22306058 | Hypoglycaemia and cardiovascular disease in type 1 diabetes. |
| PubMedID- 23940992 | Study included 313 normoalbuminuric patients with type 1 diabetes, none showed signs of adrenal, renal, or cardiovascular diseases. |
| PubMedID- 24688629 | In fact, it may be that this rapid aging of apoa-1, a key protein in lipoprotein metabolism, causes a higher risk of macrovascular disease in persons with type 1 diabetes [22]. |
| PubMedID- 23806096 | The risk of a cardiovascular disease in type 1 diabetes is very high [30], and the role of the oxidative stress seems to very relevant in the pathogenesis of these complications in type 1 diabetes [5]. |
| PubMedID- 24130351 | The risk of a cardiovascular disease in type 1 diabetes, even still partly neglected, is very high (27). |
| PubMedID- 23210443 | Thus, hyperketonemia contributes to the risk for cardiovascular disease in type 1 diabetes. |
| PubMedID- 21330642 | Objective: pulse pressure (pp), an estimate of arterial stiffness, has been shown to be associated with incident cardiovascular disease (cvd) in patients with type 1 diabetes (t1d). |
| PubMedID- 21911774 | The need to manage the risks for cardiovascular disease associated with type 1 diabetes should be considered from childhood. |
| PubMedID- 21617108 | Longer follow-up documented a significant reduction in cardiovascular disease in patients with type 1 diabetes treated with intensive glycemic control (45). |
| PubMedID- 23564922 | The risk of cardiovascular disease in type 1 diabetes, although somewhat neglected, is very high (25). |
| PubMedID- 20668287 | Childhood trauma and prevalence of cardiovascular disease in patients with type 1 diabetes. |
| PubMedID- 20929996 | Since the availability of data from diabetes control and complications trial (dcct)/epidemiology of diabetes interventions and complications (edic) studies, there is no doubt that intensive therapy positively affects the long-term incidence of micro- and macrovascular disease in subjects with type 1 diabetes (2,3). |
| PubMedID- 23768856 | [cardiovascular disease in type 1 diabetes mellitus. |
| PubMedID- 26069717 | Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. |
| PubMedID- 23435158 | However, little is known about the subclinical stages of vascular disease in individuals with type 1 diabetes. |
| PubMedID- 20843975 | Improvements in metabolic control have already been shown to have decreased the frequency of serious complications such as proliferative retinopathy, nephropathy, and cardiovascular disease seen in patients with type 1 diabetes (15,16). |
| PubMedID- 24499591 | Even though the between-group differences in crp in the present study were small, and crp has been used as a consistent marker for evaluating the extent of cardiovascular diseases in subjects with type 1 diabetes [66-70], we suggest that others determinants, such as genetic predisposition, coping mechanisms, and environmental factors, make individuals more susceptible to changes in this inflammatory marker. |
| PubMedID- 25848912 | The association between circulating mmps and macrovascular disease in patients with type 1 diabetes has not been investigated, while studies on the associations between mmp levels and microvascular complications seem contradictory. |
| PubMedID- 20880527 | Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes. |
| PubMedID- 23243415 | One of the most widely used mouse models for cardiovascular disease in type 1 diabetes is the streptozotocin-induced diabetes model in atherosclerotic apolipoprotein e-deficient (apoe−/−) or ldl-receptor-deficient (ldlr−/−) mice. |
| PubMedID- 24357694 | A novel and potentially translational finding of this investigation is the notion that the type of glucose biomarker measurement has some intrinsic relationship to metabolic memory in understanding the natural micro- and macrovascular disease progression in patients with type 1 diabetes (fig. |
| PubMedID- 22357186 | However, it is less well known that the relative risk of cardiovascular disease in type 1 diabetes can be as much as 10-fold greater than in the healthy population, especially in women (1), being even greater than in type 2 diabetes (2). |
| PubMedID- 24083407 | The study also provides detailed physical activity levels as well as accurate data on all the other predictors of microvascular diseases in type 1 diabetes. |
| PubMedID- 23877984 | There are, however, very few studies on the risk of cerebrovascular disease in type 1 diabetes since most studies have focused on type 2 diabetes alone or together with type 1 diabetes. |
| PubMedID- 21343516 | Objective: arterial stiffness is an important predictor of cardiovascular disease in type 1 diabetes mellitus (dm). |
Page: 1